Literature DB >> 7507705

Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma.

Y Y Lu1, S C Jhanwar, J Q Cheng, J R Testa.   

Abstract

Previous cytogenetic investigations have revealed frequent deletions and other unbalanced structural rearrangements of 3p in human malignant mesothelioma. We have performed a restriction fragment length polymorphism analysis by using the polymerase chain reaction and primer sets for seven DNA markers to examine loss of heterozygosity (LOH) from 3p in 25 malignant mesotheliomas. Among 24 cases informative at one or more 3p loci, 15 (62.5%) exhibited LOH with at least one marker. Deletion mapping in these tumors indicates that the common region of chromosomal loss resides within band 3p21, in the vicinity of the D3F15S2 locus. These results suggest that allelic loss from 3p21 is a frequent occurrence in malignant mesothelioma and that one or more putative tumor suppressor genes at this site contribute to the pathogenesis of this malignancy.

Entities:  

Mesh:

Year:  1994        PMID: 7507705     DOI: 10.1002/gcc.2870090114

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  10 in total

1.  The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.

Authors:  Matthew Bott; Marie Brevet; Barry S Taylor; Shigeki Shimizu; Tatsuo Ito; Lu Wang; Jenette Creaney; Richard A Lake; Maureen F Zakowski; Boris Reva; Chris Sander; Robert Delsite; Simon Powell; Qin Zhou; Ronglai Shen; Adam Olshen; Valerie Rusch; Marc Ladanyi
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

2.  Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma.

Authors:  Brock C Christensen; E Andres Houseman; Graham M Poage; John J Godleski; Raphael Bueno; David J Sugarbaker; John K Wiencke; Heather H Nelson; Carmen J Marsit; Karl T Kelsey
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

3.  ERK2 is essential for the growth of human epithelioid malignant mesotheliomas.

Authors:  Arti Shukla; Jedd M Hillegass; Maximilian B MacPherson; Stacie L Beuschel; Pamela M Vacek; Kelly J Butnor; Harvey I Pass; Michele Carbone; Joseph R Testa; Nicholas H Heintz; Brooke T Mossman
Journal:  Int J Cancer       Date:  2011-01-06       Impact factor: 7.396

Review 4.  Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.

Authors:  J F Lechner; J Tesfaigzi; B I Gerwin
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

5.  Reduced Fhit protein expression in human malignant mesothelioma.

Authors:  Lea Pylkkänen; Henrik Wolff; Tuula Stjernvall; Aija Knuuttila; Sisko Anttila; Kirsti Husgafvel-Pursiainen
Journal:  Virchows Arch       Date:  2003-10-16       Impact factor: 4.064

6.  Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations.

Authors:  S Xiao; A Renshaw; E S Cibas; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

7.  BAP1 and cancer.

Authors:  Michele Carbone; Haining Yang; Harvey I Pass; Thomas Krausz; Joseph R Testa; Giovanni Gaudino
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

8.  Germline BAP1 mutations predispose to malignant mesothelioma.

Authors:  Joseph R Testa; Mitchell Cheung; Jianming Pei; Jennifer E Below; Yinfei Tan; Eleonora Sementino; Nancy J Cox; A Umran Dogan; Harvey I Pass; Sandra Trusa; Mary Hesdorffer; Masaki Nasu; Amy Powers; Zeyana Rivera; Sabahattin Comertpay; Mika Tanji; Giovanni Gaudino; Haining Yang; Michele Carbone
Journal:  Nat Genet       Date:  2011-08-28       Impact factor: 38.330

9.  Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis.

Authors:  A M Björkqvist; M Wolf; S Nordling; L Tammilehto; A Knuuttila; J Kere; K Mattson; S Knuutila
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

10.  Microenvironment-Dependent Phenotypic Changes in a SCID Mouse Model for Malignant Mesothelioma.

Authors:  Eva Darai-Ramqvist; Gustav Nilsonne; Carmen Flores-Staino; Anders Hjerpe; Katalin Dobra
Journal:  Front Oncol       Date:  2013-08-09       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.